ANAVEX2-73

Drug identity checked against registry records

Also recorded as Blarcamesine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004NCT04314934AVXLPhase 2, Phase 3Completed2024-06-14Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.